Brokerage Radar: Divi's Labs, Paytm Receive Positive Calls, LIC Housing Fin Gets Mixed Reviews

Divi’s Laboratories received a Hold rating from Jefferies (target: ₹6,280) despite a strong Q3 FY25 showing with 64% YoY profit growth (₹589 crore) and 25% revenue surge (₹2,319 crore). Analysts note pricing pressures in generics but remain optimistic about custom synthesis and GLP-1 opportunities.

Paytm secured an Outperform rating from Bernstein (target: ₹1,100) after resolving regulatory hurdles and expanding into Brazil’s embedded finance sector. However, concerns linger over profitability amid its $1 million stake acquisition in Seven Technology LLC.

LIC Housing Finance saw split ratings: Nomura maintains Buy (target: ₹700), citing stable asset quality, while HSBC upgraded to Hold (target: ₹600) amid market share challenges.

Sources: Jefferies, Bernstein, Nomura, HSBC – February 4, 2025.